HomeCare Guidelines

Care Guidelines

Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD

Duchenne muscular dystrophy speech delay is an important developmental concern that families and healthcare professionals should recognize. Although Duchenne muscular dystrophy (DMD) is primarily known as a genetic neuromuscular condition causing progressive muscle weakness, research has shown that some boys with DMD can also experience differences or delays in...

Guide to DMD for Parents and Teachers at School: A Complete Guide for Safety, Learning, Friendship and Inclusion

A well-structured guide to DMD for parents and teachers at school is essential for supporting children with Duchenne Muscular Dystrophy (DMD) in educational environments. DMD is a progressive neuromuscular condition that affects muscle strength, endurance, and sometimes cognitive functioning. These challenges directly influence how a child participates in school...
spot_img

Keep exploring

Bone & Joint Health in Duchenne Muscular Dystrophy: Complete Care Guide

Bone & joint health in Duchenne muscular dystrophy is a critical yet often under-recognized...

Fat Embolism Syndrome in Patients with Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a progressive genetic disorder characterized by muscle degeneration and...

Vaccinations in Duchenne Muscular Dystrophy: Essential Protection for Patients and Families

Vaccinations in Duchenne muscular dystrophy (DMD) play a crucial role in protecting patients from...

Infection in Duchenne Muscular Dystrophy – Risks, Types, Prevention, and Treatment

Duchenne muscular dystrophy (DMD) is a severe genetic neuromuscular disorder characterized by progressive muscle...

Autism Spectrum Disorders in Duchenne Muscular Dystrophy: Genetics, Brain Mechanisms, and Clinical Insights

Duchenne muscular dystrophy (DMD) is a severe X-linked genetic disorder caused by mutations in...

Best Respiratory Devices for Duchenne Muscular Dystrophy Patients: Complete Guide to Breathing Support

Respiratory devices for Duchenne muscular dystrophy play a critical role in managing breathing complications...

Nutraceuticals for Duchenne Muscular Dystrophy: Supplements That May Reduce Muscle Inflammation

Duchenne Muscular Dystrophy (DMD) is one of the most severe inherited neuromuscular disorders, primarily...

Palliative Care in Duchenne Muscular Dystrophy: Complete Guide for Families

Duchenne muscular dystrophy is a progressive genetic condition that affects muscle strength and function...

Maintaining for Lung Muscles in Duchenne Muscular Dystrophy: Comprehensive Respiratory Health Care

Duchenne Muscular Dystrophy (DMD) is a progressive genetic disorder characterized by the weakening of...

Best Foods and Nutrition Plan for Duchenne Muscular Dystrophy (DMD)

Duchenne muscular dystrophy (DMD) is a progressive genetic neuromuscular disorder characterized by muscle degeneration,...

Traveling with Duchenne Muscular Dystrophy: Complete Family Guide

Duchenne Muscular Dystrophy travel requires thoughtful preparation, flexibility, and the right support to ensure...

Swallowing Difficulty (Dysphagia) in Duchenne Muscular Dystrophy (DMD): Causes, Impact, and Treatment Options

Swallowing difficulty, medically known as dysphagia, is a common but often under-recognized complication of...

Latest articles

Entrada Therapeutics ENTR-601-45: Early Exon 45 Skipping Study Shows Increased Dystrophin Production

Entrada Therapeutics has announced positive initial results from its Exon 45 Skipping Study, ELEVATE-45-201,...

Entrada Therapeutics Advances ENTR-601-44 to 18 mg/kg in Its Duchenne Exon 44 Skipping Study

Entrada Therapeutics has received clearance to test the highest dose in its Exon 44...

Sapreme Therapeutics Reports Strong Preclinical Dystrophin Restoration With SPM-2551 in Duchenne

Sapreme Therapeutics has announced promising preclinical results for SPM-2551, an experimental treatment for Duchenne...

Deramiocel Shows Positive 24-Month HOPE-3 Results in Duchenne

Capricor Therapeutics has reported new results from the HOPE-3 study evaluating Deramiocel in people...

Ractigen Therapeutics Reports Positive First-in-Human Data for RAG-18 in Duchenne

Ractigen Therapeutics has presented positive first-in-human data for RAG-18 (NCT07282652), an investigational treatment for...

Entrada Therapeutics’ ENTR-601-44 Shows Dose-Dependent Exon 44 Skipping in Early PK/PD Data

Entrada Therapeutics’ ENTR-601-44 is an investigational therapy designed for patients with Duchenne muscular dystrophy...

NS Pharma’s Brogidirsen Shows 5-Year Clinical Data in DMD Patients Amenable to Exon 44 Skipping

NS Pharma’s brogidirsen (NS-089/NCNP-02) is an investigational therapy for Duchenne muscular dystrophy (DMD) designed...

ELEVIDYS WMS 2026 Data: What They Show—and What They Don’t

Sarepta Therapeutics has presented new data on ELEVIDYS (delandistrogene moxeparvovec) at the 2026 World...